Literature DB >> 17588587

Endogenous testosterone and serum lipids in middle-aged men.

Juuso I Mäkinen1, Antti Perheentupa, Kerttu Irjala, Pasi Pöllänen, Juha Mäkinen, Ilpo Huhtaniemi, Olli T Raitakari.   

Abstract

BACKGROUND: The role of decreasing testosterone levels influencing lipid metabolism in aging men is not well established.
METHODS: We studied 1619 40 to 69-year old men with andropausal symptoms, who underwent measurements of serum testosterone, triglycerides, total-, and HDL-cholesterol.
RESULTS: Testosterone (mean 15.25 nmol/l+/-5.43 S.D., range 3.6-45.0 nmol/l) correlated directly with HDL-cholesterol (r=0.24, p<0.0001) and inversely with total cholesterol (r=-0.06, p<0.03), triglycerides (r=-0.30, p<0.0001) and body mass index (r=-0.34, p<0.0001), but not with LDL-cholesterol (r=0.05, p=0.09). In multivariate analyses adjusted for age, body mass index, smoking, alcohol consumption, diabetes and cardiovascular diseases, the significant determinants for serum triglycerides were testosterone (beta=-0.03, p<0.0001), age (beta=-0.01, p<0.0001), body mass index (beta=0.039, p<0.0001) and cardiovascular diseases (beta=0.09, p<0.04). The multivariate correlates of HDL-cholesterol included testosterone (beta=0.007, p<0.0001), body mass index (beta=-0.02, p<0.0001) and alcohol consumption (beta=0.02, p<0.0001).
CONCLUSIONS: We conclude that in aging men low testosterone levels are associated with a potentially atherogenic lipid profile including high triglycerides and low HDL-cholesterol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588587     DOI: 10.1016/j.atherosclerosis.2007.05.009

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  22 in total

1.  Effect of treatment with testosterone on endothelial function in hypogonadal men: a systematic review and meta-analysis.

Authors:  Andrea Sansone; Giulia Rastrelli; Angelo Cignarelli; Maurizio de Rocco Ponce; Rosita Angela Condorelli; Elisa Giannetta; Elisa Maseroli; Sara Pinto; Ciro Salzano; Daniele Santi
Journal:  Int J Impot Res       Date:  2019-06-24       Impact factor: 2.896

2.  Occurrence of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome in patients with abdominal obesity. Where is a sufficient level of testosterone?

Authors:  Juraj Fillo; Jan Breza; Michaela Levčíkova; Jan Luha; Anna Vachulova; Štefan Durdík; Peter Labaš
Journal:  Int Urol Nephrol       Date:  2012-08       Impact factor: 2.370

3.  Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold.

Authors:  Minoru Kobayashi; Tomoya Mizuno; Hideo Yuki; Tsunehito Kambara; Hironori Betsunoh; Akinori Nukui; Hideyuki Abe; Yoshitatsu Fukabori; Masahiro Yashi; Takao Kamai
Journal:  Int J Clin Oncol       Date:  2019-08-22       Impact factor: 3.402

Review 4.  The role of testosterone therapy in cardiovascular mortality: culprit or innocent bystander?

Authors:  Monique S Tanna; Arthur Schwartzbard; Jeffery S Berger; Joseph Alukal; Howard Weintraub
Journal:  Curr Atheroscler Rep       Date:  2015-03       Impact factor: 5.113

5.  Testosterone and insulin resistance in the metabolic syndrome and T2DM in men.

Authors:  Preethi M Rao; Daniel M Kelly; T Hugh Jones
Journal:  Nat Rev Endocrinol       Date:  2013-06-25       Impact factor: 43.330

Review 6.  Lipid effects of endocrine medications.

Authors:  Dan V Mihailescu; Avni Vora; Theodore Mazzone
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

7.  Hypogonadism, ADAM, and hormone replacement.

Authors:  Michael R Pinsky; Wayne J G Hellstrom
Journal:  Ther Adv Urol       Date:  2010-06

8.  An update on testosterone, HDL and cardiovascular risk in men.

Authors:  Arthi Thirumalai; Katya B Rubinow; Stephanie T Page
Journal:  Clin Lipidol       Date:  2015

9.  Endogenous androgen deficiency enhances diet-induced hypercholesterolemia and atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Nicholas W Hatch; Sarah J Srodulski; Huei-Wei Chan; Xuan Zhang; Lisa R Tannock; Victoria L King
Journal:  Gend Med       Date:  2012-09-13

Review 10.  Vascular Pathways of Testosterone: Clinical Implications.

Authors:  Margarida Lorigo; Melissa Mariana; Nelson Oliveira; Manuel C Lemos; Elisa Cairrao
Journal:  J Cardiovasc Transl Res       Date:  2019-12-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.